At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.
POSTED
08-10-10
Merck, a global healthcare leader working to help the world to be well, and Sesame Workshop, the nonprofit educational organization behind Sesame Street, are partnering to develop Food for Thought: Eating Well on a Budget, a bilingual education outreach pro...
POSTED
06-24-10
Merck today announced plans to initiate a Phase II investigational proof-of-concept clinical study to evaluate its oral antifungal agent posaconazole for the treatment of chronic Chagas disease. Chagas disease results from infection with the parasite Trypanosoma cruzi
POSTED
06-21-10
The UNCF/Merck Science Initiative (UMSI)--a partnership between UNCF (the United Negro College Fund), the nation's largest and most effective minority education organization, and Merck, a global healthcare leader working to help the world be well, today anno...
POSTED
06-21-10
Merck and Codexis, Inc. (NASDAQ:CDXS) today announced that they have jointly been awarded the annual Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency (EPA) for the development of a novel biocatalytic method for the synthesis of sitag...
POSTED
05-05-10
The Royal Government of Bhutan, Merck (which is known as MSD outside the United States and Canada) and the Australian Cervical Cancer Foundation (ACCF) today launched a national vaccination program with GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Va...
POSTED
03-02-10
Merck & Co., Inc. announced today that it has received a 2010 ENERGY STAR® Sustained Excellence Award from the U.S. Environmental Protection Agency (EPA) for its continued efforts to protect the environment through energy efficiency.
Merck...
POSTED
01-14-10
The Merck Company Foundation announced today a round of 30 "Neighbor of Choice" grants, totaling $809,000, to organizations throughout New Jersey. The Merck Company Foundation formerly focused its New Jersey Neighbor of Choice (NJ NOC) grants program to organizations near it...
POSTED
09-30-09
Today Merck launched its 2008 global corporate responsibility (CR) report in which it emphasized that the fundamentals of good corporate governance and accountability, ethical business practices, and transparency have never been more important.
POSTED
09-17-09
The Wellcome Trust and Merck & Co., Inc. today announced the creation of the MSD Wellcome Trust Hilleman Laboratories (www.hillemanlaboratories.in), the first of its kind research and development joint vent...
POSTED
09-08-09
Merck said today that it has been named to the Dow Jones Sustainability North America Index, published last week. This is the first time Merck has been included on the Index.
Dow Jones Sustainability's annual review considers sustainability lea...